The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

This interview discusses Little Green Pharma’s (ASX:LGP) record-breaking quarterly results for June 2024, highlighting a 12% increase in revenue and significant cash receipts. CEO Paul Long elaborates on the company’s growth drivers, including new product sales in Australia and Europe, and outlines their strategy to maintain market share and expand in emerging European markets.

lgp by the numbers
More From The Market Online

Temas Resources confirms significant gallium and scandium at La Blache

Temas Resources’ latest assays show the La Blache project in Quebec is a genuine multi-metal, multi-revenue…

GoldArc Resources begins major drilling campaigns at Leonora South

GoldArc is running RC and AC drilling programs in tandem at Leonora South in Western Australia…
The Market Online Video

The ASX Today: Relative calm didn’t last long as Brent back to US$100/bbl; March RBA hike priced in?

Greetings and welcome to HotCopper’s the ASX Today, I’m Jon Davidson and after an attack on a Thai cargo ship in the Strait of Hormuz

Magnum Mining and Exploration ramping up exploration at Parker project

Magnum Mining and Exploration is preparing for drilling at the Parker project in Arizona on the…